AI & Digital Health Resources for Life Sciences Companies
The Resource Page, created by BioNJ’s AI/Digital Health Committee, is a comprehensive repository designed to support BioNJ Members in navigating the integration and application of artificial intelligence (AI) within the life sciences sector. This initiative addresses the growing importance and potential of AI in transforming various aspects of the industry, from drug discovery and development to Patient care and operational efficiency.
BioNJ Members are invited to submit up to three AI and Digital Health Resources in the categories listed below by emailing them to [email protected]. Future BioNJ Members are welcome to submit one resource.
Industry Reports & Articles
- Boston Consulting Group: Imagine This…When AI Comes from Knowledge Workers
- Deloitte: Scaling for Tangible Results
- Deloitte: AI in Pharma and Life Sciences: Discover How AI is Transforming Pharma
- EY: How to Build a Foundation in AI to Accelerate Health Transformation
- EY: Generative AI Venture Capital Investment Globally on Track to Reach $12 Billion in 2024, Following Breakout Year in 2023
- IBM: Delivering Responsible AI in the Healthcare and Life Sciences Industry
- IBM: Leveraging generative AI on AWS to transform life sciences – IBM Blog
- McKinsey & Company: Generative AI in the Pharmaceutical Industry: Moving from Hype to Reality
- McKinsey & Company: What’s the Future of AI?
- Morgan Stanley: Healthcare: AI Tech Diffusion in Healthcare: Distilling Signal from Noise (ms.com)
- Morgan Stanley: Video | Thematics: AI in Action: Sector Series – Biotech (ms.com)
- Morgan Stanley: Video | Thematics: AI in Action: Sector Insights – Pharma (ms.com)
- PwC: AI and Generative AI in 2023: Four Top Questions Answered
- PwC: How to Leverage Generative AI to Unlock Value and Reinvent Your Business
- Stifel: AI in Biopharma
Responsible Use of AI
Public/Private Partnerships
- Governor Murphy and Princeton University Announce Plans to Establish Artificial Intelligence Hub in New Jersey
- New Initiatives Bring Princeton to the Fore of AI innovation
- New Jersey Economic Development Authority AI Hub Request for Information
- BioNJ Response to New Jersey’s Artificial Intelligence Hub RFI
- Driving U.S. Innovation in Artificial Intelligence
Responsible Use of AI by Biopharma
- GSK: Our Position on Responsible Artificial Intelligence (AI)
- Johnson & Johnson: Doing the Right Thing: AI & Ethics
- Merck & Co.: Merck’s Commitment to Developing and Using Artificial Intelligence Ethically and Responsibly
- Novartis: Commitment to the Ethical and Responsible Use of Artificial Intelligence (AI) Systems
- Pfizer: Policy Position on Artificial Intelligence
- Regeneron: Position Statement on Responsible Use of Artificial Intelligence
Regulatory Guidance Documents
- U.S. Regulatory Documents:
- Artificial Intelligence and Medical Products: How CBER, CDER, CDRH and OCP are Working Together
- Artificial Intelligence and Machine Learning in Software as a Medical Device
- Software Associated With Prescription Drugs: Opportunities to Enhance Safe and Effective Medication Use
- Regulatory Considerations for Prescription Drug Use-Related Software
- UK/EU Regulatory Documents:
Other Free Courses
- Stanford:
- University of Pennsylvania:
- Vanderbilt:
